Over time, studies have shown the importance of determining serotonin levels to diagnose somatic and psychiatric disorders. There are theoretical premises and practical ways to achieve a subtle correlation between the existence of comorbid psychiatric disorders and somatic diseases caused by the changes observed in serotonin levels. The present study, classified as retrospective and quantitative, provides evidence for determining the serotonin levels in patients with diabetes and anxiety or depression. A total of 48 patients with diabetes type 2 were enrolled in the study. Blood glucose level, glycated haemoglobin, and serum serotonin were noted, and they completed Hamilton A and Beck Depression Inventory questionnaires. We found robust correlations between serum serotonin and blood glucose (Sig. = 0.008), serum serotonin and HbA1c (Sig. = 0.007), serum serotonin and anxiety (Sig. = 0.000), and serum serotonin and depression (Sig. = 0.000). It is also noteworthy that women recorded extreme values higher than men for glycated haemoglobin (95% confidence interval: 6.92–7.79 in women and 6.30–7.23 in men). In conclusion, using serotonin as a marker of the mentioned diseases in clinical practice is of significant utility, considering the benefits in terms of the evolution and prognosis of comorbidities in patients with type 2 diabetes and anxiety and depressive symptoms.
The outbreak of SARS-CoV-2 pandemic has resulted in increased rates of anxiety and depression worldwide. Objective. To comparatively evaluate factors associated with the psychological impact of Coronavirus disease between 2019 and the pandemic year 2020. Materials and Methods. The study was performed on a group of 3224 patients, of which 197 were hospitalized, selected from 1 Jan 2019 until 30 Dec 2020 in a tertiary care center for psychiatric disorders. Data were collected from the observation charts. Results. The incidence of anxiety disorders is higher in the age range 40–70 years with an average value of 53 years old. In 2019, a third of patients (29.45%) had alcohol-related conditions and developed anxiety-depressive disorder. In 2020, the percentage was lower (9.38%), but also the number of admitted patients significantly decreased (p < 0.0001). There were not found significant differences in age, gender or environment. Hypnotic disorders were more predominant in 2019 (54.6% vs. 37.5%, p = 0.01), whereas in 2020 anxiety and agitation increased significantly (34.4% vs. 84.38%, p = 0.0001). Relapses were similarly frequent in both years, in half of the cases. Conclusions. Coronavirus pandemic lead to a decrease in both presentations and admission to hospital. Although there were not found significant differences in age or gender, more patients from urban environment were admitted, which can have several explanations. Anxiety and agitation became the main reason for hospitalization in 2020.
Background/Objectives: Psychiatric morbidity is frequent in oncology, yet prevalence and correlates differ across tumour sites. Urogenital cancers, in particular, involve psychosocial stressors related to sexuality, fertility, continence, and body image, which may intensify anxiety and depression. This study aimed to estimate the proportion of psychiatric morbidity among psychiatry-assessed oncology inpatients in a real-world hospital setting to compare urogenital with non-urogenital malignancies and to examine clinical correlates and hospitalisation outcomes. Methods: We conducted a retrospective analysis of 174 oncology inpatients who were evaluated by liaison psychiatry and completed the Hospital Anxiety and Depression Scale (HADS) during admission to a tertiary hospital in Galați, Romania, between 2019 and 2022. All patients completed the Hospital Anxiety and Depression Scale (HADS) and underwent liaison psychiatry evaluation. Mixed anxiety–depressive disorder (ICD-10 F41.2) was the primary psychiatric outcome. Demographic, clinical, and functional data—including Eastern Cooperative Oncology Group (ECOG) performance status—were extracted from medical records. Comparative and multivariable analyses were performed to identify predictors of severe depressive symptoms (primary outcome, HADS-D ≥ 11) and to explore associations with length of stay and costs. Results: Overall, 59% of patients had elevated HADS-Anxiety and 62% elevated HADS-Depression, while 40% received a psychiatric diagnosis. Mixed anxiety–depressive disorder predominated, especially in cervical (95%), bladder (100%), and prostate (≈70–75%) cancers. Urogenital cancers showed significantly higher rates of anxiety/depression than non-urogenital cancers (85% vs. 46%, p < 0.01). Poorer ECOG status independently predicted severe depressive symptoms (OR 3.6, 95% CI 2.1–6.2, p < 0.001). Psychiatric morbidity was associated with a trend toward longer LOS (median 12 vs. 9 days, p ≈ 0.08) and ≈10% higher hospital costs. Conclusions: Anxiety and depression were highly frequent among psychiatry-assessed oncology inpatients, particularly in urogenital malignancies. Functional impairment strongly correlates with psychiatric morbidity. These findings underscore the need for systematic screening and risk-stratified psycho-oncologic interventions to improve patient outcomes and resource utilisation.
6 February 2024 in BRAIN. BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE
The subject of anxiety related to dental treatments is recognized and long debated in medical literature. There are various motivations, starting with individual, age-related, social, economic or strictly medical reasons. Considering the medical and psychological importance of oral health that impact the whole organism health, there is an increasingly sustained, interdisciplinary concern, with the involvement of dentists, generalists, psychologists or psychiatrists. This situation is quantified at the individual and social level with reference to both the financial costs and the organic and psychological suffering determined by this medico-psycho-social problem. This is why the authors of this article proposed in the current study to determine if there is a difference in terms of anxiety towards dental treatments in subjects trained from a medical point of view versus people without medical instruction. The study used an online questionnaire and was carried out over a period of one month in the year 2023. The data were processed with the help of LibreOffice Calc and Microsoft Excel. The conclusions of the study revealed that poor oral health can serve as a precursor to anxiety and depression, creating a link between oral hygiene and mental well-being. Oral pain, embarrassment and the resulting self-consciousness can contribute to feelings of anxiety and depression, feelings that exist no matter if there were subjects trained in medical field or not, therefore individuals may have difficulty socializing, communicating, and maintaining a positive self-image.
The context of the Coronavirus pandemic has fundamentally changed the way we approach medical services. Beyond setting up new technological possibilities, it has propelled telemedicine to become a reality, bringing undeniable practical benefits. The questions that arise are both justified and worrying: can digitalization replace a direct interpersonal relationship that involves a physical examination, while preserving the quality of the medical act and the degree of patient satisfaction? Isn't there a risk that the digitization of the medical record will cancel out the deep human character of classical medicine that has evolved since the time of Hippocrates? Should the implementation of telemedicine be "the state-of-art" of modern medicine, in accordance with the co-evolution of digital technology? It is hard to believe that once used in this period, telemedicine will be abandoned. However, telemedicine must be analyzed not only in the short term but also in the long term, in order to be able to evaluate both its usefulness and possible deficiencies.
Background: Patients undergoing dental treatment often experience psychological distress and social discomfort, yet longitudinal data on these changes are limited. Existing studies rely on cross-sectional designs or lengthy tools, reducing feasibility in routine practice. This study explored psychological and social trajectories during dental care, highlighting challenges and implications for patient wellbeing and care delivery. Methods: A prospective cohort study with repeated measures across three dental visits (V1–V3) was conducted. Participants completed a 21-item binary (yes/no) questionnaire assessing psychological (Q1–Q6) and social dimensions (Q7–Q14 at all visits; extended social domain Q7–Q21 at V2–V3). Composite scores were calculated, and longitudinal changes were analyzed using generalized estimating equations or mixed-effects models. Item-level trajectories were examined with multiple comparison adjustments. Results: Of 120 enrolled patients, 100 completed all visits. Psychological well-being consistently improved, while social outcomes showed more complex, domain-specific patterns. Item-level analyses revealed gains in appearance and satisfaction, whereas stigma, fear, and social integration remained relatively stable, underscoring the need to monitor multiple psychosocial dimensions. Conclusions: Psychosocial monitoring during dental care is feasible and potentially beneficial. The 21-item questionnaire was practical and well-accepted, with composite scores serving as simple indicators for tracking patient wellbeing and supporting a holistic, patient-centered approach. Further validation in larger and more diverse populations is needed.